February 19, 2025

Study Identifies Skin Lipid Biomarkers for Atopic Dermatitis

Reduced levels of protein-bound ceramides at 6 weeks were associated with an increased risk of atopic dermatitis by age 1 year, according to a new study in JACI.

Conexiant

February 19, 2025

FDA Clears Novel Atopic Dermatitis Drug

FDA grants IND clearance to Zabalafin Hydrogel, a botanical drug targeting bacterial, inflammatory, and pruritic components of atopic dermatitis, following successful Phase 2a trials.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

Skin Disease in Kids Linked to Sleep Disorders

Children with psoriasis had a 3.2-fold higher risk for hypersomnia, sleep apnea, and nearly double the risk for depression, researchers report.

Conexiant

February 07, 2025

Hematologic Indicators Linked to Alopecia Areata Severity

Researchers analyze hematological ratios in alopecia areata severity assessment.

Conexiant

February 03, 2025

Key Comorbidities Elevate Risk of Severe Alopecia Areata

Study finds bronchial asthma, dermatitis, and thyroiditis significantly increase risk for early-onset, severe, and prolonged alopecia areata.

Conexiant

January 24, 2025

New Oral Psoriasis Drug Demonstrates Promising Safety

BI 730357 achieved PASI 75 in 30% of patients with plaque psoriasis at 200 mg qd, showing moderate efficacy and tolerability.

Conexiant

April 26, 2024

Wildfires May Have Triggered Skin Disease Flare-ups in Northeastern United States

The number of visits to dermatologists for atopic dermatitis and eczema may have increased during the summer months of 2023 following the Canadian wildfires.

Conexiant

May 28, 2024

Study Links Blood Pressure Meds to Eczema Risk in Seniors

Antihypertensive drugs linked to small increased risk of eczema in older adults, with diuretics and calcium channel blockers showing the highest risk, study finds.

Conexiant